![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: LINC02163 |
Gene summary for LINC02163 |
![]() |
Gene information | Species | Human | Gene symbol | LINC02163 | Gene ID | 107986389 |
Gene name | long intergenic non-protein coding RNA 2163 | |
Gene Alias | LINC02163 | |
Cytomap | 5q21.2 | |
Gene Type | ncRNA | GO ID | NA | UniProtAcc | NA |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
107986389 | LINC02163 | AEH-subject1 | Human | Endometrium | AEH | 4.06e-07 | 2.13e-01 | -0.3059 |
107986389 | LINC02163 | AEH-subject2 | Human | Endometrium | AEH | 3.05e-36 | 8.21e-01 | -0.2525 |
107986389 | LINC02163 | AEH-subject3 | Human | Endometrium | AEH | 7.64e-34 | 7.25e-01 | -0.2576 |
107986389 | LINC02163 | AEH-subject4 | Human | Endometrium | AEH | 1.32e-04 | 2.57e-01 | -0.2657 |
107986389 | LINC02163 | AEH-subject5 | Human | Endometrium | AEH | 9.46e-93 | 1.47e+00 | -0.2953 |
107986389 | LINC02163 | EEC-subject2 | Human | Endometrium | EEC | 2.07e-72 | 1.12e+00 | -0.2607 |
107986389 | LINC02163 | EEC-subject3 | Human | Endometrium | EEC | 5.97e-26 | 7.76e-01 | -0.2525 |
107986389 | LINC02163 | EEC-subject4 | Human | Endometrium | EEC | 1.30e-14 | 4.68e-01 | -0.2571 |
107986389 | LINC02163 | EEC-subject5 | Human | Endometrium | EEC | 2.66e-23 | 5.86e-01 | -0.249 |
107986389 | LINC02163 | RNA-P17T-P17T-2 | Human | Lung | IAC | 6.80e-05 | 6.42e-01 | 0.3371 |
107986389 | LINC02163 | RNA-P17T-P17T-4 | Human | Lung | IAC | 1.48e-03 | 6.76e-01 | 0.343 |
107986389 | LINC02163 | RNA-P17T-P17T-6 | Human | Lung | IAC | 1.46e-13 | 1.15e+00 | 0.3385 |
107986389 | LINC02163 | RNA-P17T-P17T-8 | Human | Lung | IAC | 1.77e-07 | 8.11e-01 | 0.3329 |
Page: 1 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Breast | Precancer | ![]() |
Breast | IDC | ![]() |
Breast | DCIS | ![]() |
Cervix | CC | ![]() |
Cervix | HSIL_HPV | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |